Development-stage biopharma and healthtech companies often raise capital without a clear view of where investors are actually placing bets and why. Roots Analysis, an independent life-sciences intelligence provider, delivers Investment Analysis that maps funded competitors, investment trends, and investor sentiment within target sectors. The framework covers competitor funding and investor mapping (rounds, valuations, capital patterns), deal intelligence and risk assessment (investor criteria, stage preferences, deal-breakers), and investor exit and valuation forecasting (historical exits, opportunity sizing). Clients use these insights to refine fundraising pitches, align portfolio development with investor priorities, and anticipate potential back-outs or acquisition windows. For CFOs, BD leads, and founders, third-party investment analysis transforms scattered deal data into a compelling, evidence-based investor narrative. Explore how Roots Analysis strengthens fundraising and deal strategy: https://www.rootsanalysis.com/competitive-intelligence/investment-analysis/